BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32614890)

  • 1. Oncoprotein 18 is necessary for malignant cell proliferation in bladder cancer cells and serves as a G3-specific non-invasive diagnostic marker candidate in urinary RNA.
    Hanke M; Dubois J; Kausch I; Petkovic S; Sczakiel G
    PLoS One; 2020; 15(7):e0229193. PubMed ID: 32614890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing Op18/stathmin by RNA Interference Promotes the Sensitivity of Nasopharyngeal Carcinoma Cells to Taxol and High-Grade Differentiation of Xenografted Tumours in Nude Mice.
    Lin X; Yu T; Zhang L; Chen S; Chen X; Liao Y; Long D; Shen F
    Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):611-620. PubMed ID: 27289016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancer.
    Reiswich V; Könemann S; Lennartz M; Höflmayer D; Menz A; Chirico V; Hube-Magg C; Fraune C; Bernreuther C; Simon R; Clauditz TS; Sauter G; Hinsch A; Kind S; Jacobsen F; Steurer S; Minner S; Büscheck F; Burandt E; Marx AH; Lebok P; Krech T
    Pathol Res Pract; 2022 Sep; 237():154028. PubMed ID: 35872365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vinblastine differs from Taxol as it inhibits the malignant phenotypes of NSCLC cells by increasing the phosphorylation of Op18/stathmin.
    Shen F; Long D; Yu T; Chen X; Liao Y; Wu Y; Lin X
    Oncol Rep; 2017 Apr; 37(4):2481-2489. PubMed ID: 28259950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protumorigenic overexpression of stathmin/Op18 by gain-of-function mutation in p53 in human hepatocarcinogenesis.
    Singer S; Ehemann V; Brauckhoff A; Keith M; Vreden S; Schirmacher P; Breuhahn K
    Hepatology; 2007 Sep; 46(3):759-68. PubMed ID: 17663418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro neutralization of autocrine IL‑10 affects Op18/stathmin signaling in non‑small cell lung cancer cells.
    Zhao Y; Chen S; Shen F; Long D; Yu T; Wu M; Lin X
    Oncol Rep; 2019 Jan; 41(1):501-511. PubMed ID: 30320402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of TMEM40 is associated with the malignant behavior and tumorigenesis in bladder cancer.
    Zhang ZF; Zhang HR; Zhang QY; Lai SY; Feng YZ; Zhou Y; Zheng SR; Shi R; Zhou JY
    J Transl Med; 2018 Jan; 16(1):9. PubMed ID: 29351801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation-stage specific expression of oncoprotein 18 in human and rat prostatic adenocarcinoma.
    Friedrich B; Grönberg H; Landström M; Gullberg M; Bergh A
    Prostate; 1995 Aug; 27(2):102-9. PubMed ID: 7638082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria.
    Kim WT; Jeong P; Yan C; Kim YH; Lee IS; Kang HW; Kim YJ; Lee SC; Kim SJ; Kim YT; Moon SK; Choi YH; Kim IY; Yun SJ; Kim WJ
    Oncotarget; 2016 Sep; 7(36):58193-58202. PubMed ID: 27528424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of oncoprotein 18 correlates with poor differentiation in lung adenocarcinomas.
    Chen G; Wang H; Gharib TG; Huang CC; Thomas DG; Shedden KA; Kuick R; Taylor JM; Kardia SL; Misek DE; Giordano TJ; Iannettoni MD; Orringer MB; Hanash SM; Beer DG
    Mol Cell Proteomics; 2003 Feb; 2(2):107-16. PubMed ID: 12644570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction of exogenous wild‑type p53 mediates the regulation of oncoprotein 18/stathmin signaling via nuclear factor‑κB in non‑small cell lung cancer NCI‑H1299 cells.
    Chen S; Zhao Y; Shen F; Long D; Yu T; Lin X
    Oncol Rep; 2019 Mar; 41(3):2051-2059. PubMed ID: 30628717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Op18/stathmin is involved in the resistance of taxol among different epithelial carcinoma cell lines.
    Lin X; Liao Y; Xie J; Liu S; Su L; Zou H
    Cancer Biother Radiopharm; 2014 Nov; 29(9):376-86. PubMed ID: 25379611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CD147, BIGH3 and Stathmin and their potential role as diagnostic marker in patients with urothelial carcinoma of the bladder.
    Bhagirath D; Abrol N; Khan R; Sharma M; Seth A; Sharma A
    Clin Chim Acta; 2012 Oct; 413(19-20):1641-6. PubMed ID: 22626996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Oncoprotein 18/Stathmin Signaling by ERK Concerns the Resistance to Taxol in Nonsmall Cell Lung Cancer Cells.
    Lin X; Liao Y; Chen X; Long D; Yu T; Shen F
    Cancer Biother Radiopharm; 2016 Mar; 31(2):37-43. PubMed ID: 26881937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aneugenic activity of Op18/stathmin is potentiated by the somatic Q18-->e mutation in leukemic cells.
    Holmfeldt P; Brännström K; Stenmark S; Gullberg M
    Mol Biol Cell; 2006 Jul; 17(7):2921-30. PubMed ID: 16624860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder.
    Han Y; Liu Y; Nie L; Gui Y; Cai Z
    Urology; 2013 Jan; 81(1):209.e1-7. PubMed ID: 23153939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary levels of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein as a diagnostic biomarker in patients with bladder cancer.
    Nitta Y; Konishi H; Makino T; Tanaka T; Kawashima H; Iovanna JL; Nakatani T; Kiyama H
    BMC Urol; 2012 Sep; 12():24. PubMed ID: 22943287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-associated fibroblasts promote cisplatin resistance in bladder cancer cells by increasing IGF-1/ERβ/Bcl-2 signalling.
    Long X; Xiong W; Zeng X; Qi L; Cai Y; Mo M; Jiang H; Zhu B; Chen Z; Li Y
    Cell Death Dis; 2019 May; 10(5):375. PubMed ID: 31076571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oestrogen promotes tumorigenesis of bladder cancer by inducing the enhancer RNA-eGREB1.
    Ding M; Liu Y; Li J; Yao L; Liao X; Xie H; Yang K; Zhou Q; Liu Y; Huang W; Cai Z
    J Cell Mol Med; 2018 Dec; 22(12):5919-5927. PubMed ID: 30252203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing stathmin-modulating efficiency of chemotherapy for esophageal squamous cell cancer with paclitaxel.
    Feng W; Xiaoyan X; Xuan Y; Xiangke L; Zichang Y; Ran Z; Liuxing W; Qingxia F
    Cancer Gene Ther; 2015 Apr; 22(3):115-21. PubMed ID: 25572118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.